Preprint · OA
via OpenAlex
Effects of NAD⁺ Repletion with Nicotinamide Riboside on Obesity-Induced Chronic Kidney Disease
Morgange Decarnoncle, Louise Pierre, Rouzé, Pauline, Inès Jadot, Anne‐Émilie Declèves, Florian Juszczak
ORBi UMONS
Abstract
peer reviewed
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- Canonical
- link ↗
- Fetched
- 2026-10-09 MST
Cite this
APA
Decarnoncle, M., Pierre, L., Pauline, R., Jadot, I., Declèves, A., & Juszczak, F. (n.d.). Effects of NAD⁺ Repletion with Nicotinamide Riboside on Obesity-Induced Chronic Kidney Disease. <em>ORBi UMONS</em>. https://openalex.org/W7139591953
Vancouver
Decarnoncle M, Pierre L, Pauline R, Jadot I, Declèves A, Juszczak F. Effects of NAD⁺ Repletion with Nicotinamide Riboside on Obesity-Induced Chronic Kidney Disease. ORBi UMONS.
BibTeX
@unpublished{morgangendEffect,
title = {Effects of NAD⁺ Repletion with Nicotinamide Riboside on Obesity-Induced Chronic Kidney Disease},
author = {Morgange Decarnoncle and Louise Pierre and Rouzé, Pauline and Inès Jadot and Anne‐Émilie Declèves and Florian Juszczak},
journal = {ORBi UMONS},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Springer eBooks 2016
Citation only
Vitamin D and Klotho in Chronic Kidney Disease
Advances in experimental medicine and biology 2012
Preprint · OA
Secreted Klotho and Chronic Kidney Disease
Clinica Chimica Acta 2020
Citation only
Bone, inflammation and chronic kidney disease
Nature Communications 2018
Open access · CC-BY
Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults
Scientific Reports 2026
Open access · CC-BY
Effects of NAD⁺ repletion with Nicotinamide riboside on obesity-induced chronic kidney disease and renal cell lipotoxicity
Molecular Catalysis 2024
Citation only